Main
Portfolio Index > 2004 Genetic
Index > Molecular Pharma
NIDA Genetics Molecular Pharma Portfolio Listing A - Z
|
|
|
ABOOD, MARY |
Molecular
Mechanisms of Cannabinoid Receptor Regulation |
|
5R01DA009978-07 |
|
|
AKIL, HUDA |
ORPHANIN
SYSTEM--ROLE IN STRESS AND ADDICTION |
|
5R01DA013386-03 |
|
|
AKIL, HUDA |
Stress & Vulnerability
to Drug Abuse: Neural Correlates |
|
5R01DA013386-03 |
|
|
ALBERINI, CRISTINA |
Molecular
bases of addictive memories |
|
1R21DA017672-01 |
|
|
AMARA, SUSAN |
FUNCTIONAL
ANALYSIS OF TRANSPORTER LIGAND INTERACTIONS |
|
5P01DA012408-050002 |
|
|
AMARA, SUSAN |
MOLECULAR
STUDIES OF CATECHOLAMINE TRANSPORTERS |
|
5R37DA007595-12 |
|
|
ANDERSON, RICHARD |
Identification
of marker proteins for neuronal caveolae |
|
5R21DA014902-02 |
|
|
ANDREWS, CHRISTINE |
Genomic
and proteomic analysis of heroin administration |
|
7F32DA015257-02 |
|
|
AWTRY, TAMMY |
Chronic
Nicotine on Receptor Regulation of SERT Activity |
|
5F31DA014140-03 |
|
|
AZAM, LAYLA |
Characterization
of nAChRs using novel alpha-conotoxins |
|
1F32DA016835-01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No names at this time.
|
|
|
|
|
|
|
|
KALIVAS, PETER |
Neurobiology
of Addiction Research Center (NARC) |
|
1P50DA015369-01A1 |
|
|
KALIVAS, PETER |
GLUTAMATE
AND CRAVING FOR COCAINE |
|
1P50DA015369-01A1 |
|
|
KELLEY, ANN |
Plasticity
and learning in a corticostriatal network |
|
2R01DA004788-18 |
|
|
KELLEY, ANN |
OPIOID
SYSTEMS IN VENTRAL STRIATUM AND FOOD REWARD |
|
5R01DA009311-08 |
|
|
KELLY, MARTIN |
OPIOID
EFFECTS ON HYPOTHALAMIC NEURONAL EXCITABILITY |
|
5R01DA005158-14 |
|
|
KELSOE, JOHN |
Microarray
studies of amphetamine models of psychosis |
|
5R01DA013769-03 |
|
|
KONRADI, CHRISTINE |
PSYCHOSTIMULANT
REGULATION OF NEURAL GENE EXPRESSION |
|
5R01DA007134-14 |
|
|
KUHAR, MICHAEL |
Promoter
characterization of the CART gene |
|
5R01DA015162-02 |
|
|
KUHAR, MICHAEL |
MECHANISMS
OF DRUGS OF ABUSE |
|
5K05DA000418-05 |
|
|
KUHN, DONALD |
NEUROTOXIC
AMPHETAMINES RADICAL & 5HT NEURONS |
|
5R01DA010756-07 |
|
|
|
|
LANCELLOTTI, DANIELLA |
Morphine-induced
chronic Fra upregulation |
|
1F31DA017421-01 |
|
|
LANDAU, EMMANUEL |
Translational
control of LTP |
|
1R01DA015863-01A1 |
|
|
LANDRY, CHARLES |
GENE
EXPRESSION PROFILE IN RESPONSE TO DRUG PAIRED CUES |
|
5R01DA013780-03 |
|
|
LAW, PING-YEE |
G
PROTEINS AND OPIOID RECEPTOR FUNCTIONS |
|
5K05DA000513-03 |
|
|
LAW, PING-YEE |
G
PROTEINS AND OPIOID RECEPTOR FUNCTIONS |
|
5R01DA007339-13 |
|
|
LESTER, ROBIN |
SUBUNIT
SPECIFIC REGULATION OF NICOTINIC RECEPTORS |
|
5R01DA011940-04 |
|
|
LEVITT, PAT |
Brain
Structure & Function after Fetal Cocaine Exposure |
|
5R01DA011165-09 |
|
|
LINDBERG, IRIS |
OPIOID
PEPTIDE SYNTHESIZING ENZYMES |
|
5R01DA005084-16 |
|
|
LIU-CHEN, LEE-YUAN |
MOLECULAR
CHARACTERIZATION OF OPIOID RECEPTORS |
|
5R01DA004745-15 |
|
|
LIU-CHEN, LEE-YUAN |
REGULATION
OF KAPPA OPIOID RECEPTORS |
|
5R01DA011263-04 |
|
|
LOH, HORACE |
MOLECULAR
MECHANISM OF OPIOID RECEPTORS |
|
2P50DA011806-060004 |
|
|
LOH, HORACE |
CORE--ADMINISTRATIVE
AND SEED GRANTS |
|
2P50DA011806-069004 |
|
|
LOH, HORACE |
NEUROCHEMICAL
BASIS OF NARCOTIC ADDICTION |
|
3R01DA000564-31S1 |
|
|
LUKAS, RONALD |
Molecular
Bases for Effects of Nicotine |
|
1R01DA015389-01A1 |
|
|
|
|
MADRAS, BERTHA |
Cocaine-Molecular
Targets/Brain Imaging and Medications |
|
5K05DA015305-02 |
|
|
MADRAS, BERTHA |
Evaluation
of Novel Cocaine Medications |
|
5R01DA011558-07 |
|
|
MAGER, SELA |
SEROTONIN
AND GABA TRANSPORTERS--STRUCTURE/FUNCTION |
|
5P01DA012408-050005 |
|
|
MALDONADO-VLAAR, CARMEN |
NEURAL
AND MOLECULAR MECHANISMS IN STRIATAL LEARNING |
|
5R29DA011665-05 |
|
|
MANTSCH, JOHN |
Stress
response and HPA regulation in cocaine addiction |
|
5R01DA015758-02 |
|
|
MCKENZIE, ROBERT |
Microarray
analysis of identified neurons in the brain |
|
1R41DA016406-01 |
|
|
MEANEY, MICHAEL |
Individual
Differences in Mesolimbic Dopamine Systems |
|
5R01DA013189-03 |
|
|
MELIKIAN, HALEY |
Trafficking
and Regulation of Monoamine Transporters |
|
5R01DA015169-02 |
|
|
MELIKIAN, HALEY |
Monoamine
Transporter Phosphorylation and Trafficking |
|
5R21DA015355-02 |
|
|
MORALES, MARISELA |
GFR
alpha-1 is present in central neurons with distinct |
|
1Z01DA000407-05 |
|
|
MORALES, MARISELA |
Co-existence
Of Serotonin 3&cb1 Cannabinoid Receptors In |
|
1Z01DA000449-01 |
|
|
MORALES, MARISELA |
Serotonin
3 (5-ht3) Cb1 Cannabinoid Receptors Are Co-exp |
|
1Z01DA000450-01 |
|
|
MORALES, MARISELA |
Composition
Of 5-ht3 Receptors Synthesized In Rat Nervou |
|
1Z01DA000451-01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RAMASWAMI, MANI |
ID
of Drosophila proteins modified by neural activity |
|
5R21DA015383-02 |
|
|
RAYPORT, STEPHEN |
PSYCHOSTIMULANT
SENSITIZATION AT THE SYNAPTIC LEVEL |
|
5K02DA000356-05 |
|
|
REGGIO, PATRICIA |
Molecular
Determinants for Cannabinoid Activity |
|
2R01DA003934-16 |
|
|
REGGIO, PATRICIA |
MOLECULAR
DETERMINANTS FOR CANNABINOID ACTIVITY |
|
5K02DA000489-04 |
|
|
REITH, MAARTEN |
DOPAMINE
TRANSPORTER AND COCAINE |
|
5R01DA008379-09 |
|
|
REITH, MAARTEN |
DOPAMINE
TRANSPORTERS AND IONS, SUBSTRATES, BLOCKERS |
|
5R01DA013261-04 |
|
|
REITH, MAARTEN |
COCAINE
AND REGULATION OF THE DOPAMINE TRANSPORTER |
|
7R01DA011978-05 |
|
|
ROGERS, THOMAS |
Core--Molecular
biology |
|
5P30DA013429-049005 |
|
|
ROSS, JULIE |
Molecular
Basis of Vulnerability to Drug Addiction |
|
1F30DA016500-01 |
|
|
RUDNICK, GARY |
NEUROTRANSMITTER
TRANSPORTER STRUCTURE/FUNCTION |
|
5P01DA012408-050006 |
|
|
RUDNICK, GARY |
CORE--TRANSPORTER
DATABASE AND STRUCTURE WEBSITE |
|
5P01DA012408-059001 |
|
|
RUDNICK, GARY |
ION
AND BIOGENIC AMINE TRANSPORT MECHANISMS |
|
5R01DA007259-12 |
|
|
RUDNICK, GARY |
NEUROTRANSMITTER
TRANSPORT |
|
5R01DA008213-09 |
|
|
|
|
SADEE, WOLFGANG |
OPIOID
RECEPTOR REGULATION |
|
5R01DA004166-16 |
|
|
SANDERS-BUSH, ELAINE |
HALLUCINOGENS
AND SEROTONIN SIGNAL TRANSDUCTION |
|
5R01DA005181-14 |
|
|
SANNA, PIETRO |
GENE
EXPRESSION BASES OF COCAINE DEPENDENCE AND RELAPSE |
|
5R01DA013821-03 |
|
|
SCHILTZ, CRAIG |
Molecular
Basis of Addiction: Conditioning and Relapse |
|
1F30DA016503-01 |
|
|
SCHMIDT, HEATH |
Eph
Receptors and Behavioral Sensitization to Cocaine |
|
1F31DA016824-01 |
|
|
SEEMAN, PHILIP |
RECEPTORS
MEDIATING DRUG DEPENDENCE |
|
5R01DA007223-12 |
|
|
SELF, DAVID |
GENE
EXPRESSION AND COCAINE IN PROLONGED ABSTINENCE |
|
5R21DA013796-04 |
|
|
SHAPIRO, MATTHEW |
LEARNING
AND MEMORY DEPENDENT GENE EXPRESSION |
|
5R21DA014166-02 |
|
|
SHARP, BURT |
INTERACTION
BETWEEN NICOTINE AND STRESS |
|
5R01DA003977-20 |
|
|
SIGGINS, GEORGE |
MORPHINE
LIKE BRAIN PEPTIDES--CELLULAR NEUROBIOLOGY |
|
5R01DA003665-20 |
|
|
SIMON, ERIC |
Effects
of morphine and analogues on cell metabolism |
|
5R01DA000017-39 |
|
|
SMITH, DESMOND |
Voxelation:
a new method for 3D gene expression analysis |
|
5R01DA015802-02 |
|
|
SMITH, SHERYL |
STEROIDS
AND GABA:PHYSIOLOGY OF RECEPTOR SUBUNIT CHANGES |
|
5R01DA009618-08 |
|
|
SNODDY, JAY |
Bioinfomatics
for Mouse Phenotype Analysis |
|
5P01DA015027-02 |
|
|
SORKIN, ALEXANDER |
Dopamine
Transporter Regulation by Endocytosis |
|
5R01DA014204-03 |
|
|
STEINER, HEINZ |
Behavior/Drug
Interactions in Striatal gene Regulation |
|
5R21DA015439-02 |
|
|
STEINER, HEINZ |
OPIOID
PEPTIDES AND COCAINE ABUSE |
|
5R29DA011261-05 |
|
|
STEPHAN, MEGAN |
FUNCTIONS
OF MEMBRANE SPANS IN THE SEROTONIN TRANSPORTER |
|
5R01DA012586-03 |
|
|
SU, TSUNG |
Opioids
And Cellular Survival |
|
1Z01DA000263-09 |
|
|
SULZER, DAVID |
Presynaptic
mechanisms in dopamine neurotransmission |
|
5R01DA007418-10 |
|
|
SUMIKAWA, KATUMI |
Long-term
Potentiation and Nicotine Withdrawal |
|
5R01DA014542-02 |
|
|
SURRATT, CHRISTOPHER |
Dopamine
Transporter Structure-Function Studies |
|
1R15DA016604-01 |
|
|
SZUCS, REGINA |
ROLE
OF 5-HT2A RECEPTORS IN COCAINE-INDUCED BEHAVIOR |
|
5F30DA006059-04 |
|
|
|
|
|
|
|
|
|
|
No Names at this time.
|
|
|
|
|
|
|
|
WEINSTEIN, HAREL |
MOLECULAR
DETERMINANTS FOR THE ACTION OF HALLUCINOGENS |
|
5K05DA000060-23 |
|
|
WEINSTEIN, HAREL |
STRUCTURE/FUNCTION
OF NEUROTRANSMITTER TRANSPORTERS |
|
5P01DA012408-05 |
|
|
WEINSTEIN, HAREL |
MOLECULAR
BASIS OF TRANSPORTER AND LIGAND FUNCTION |
|
5P01DA012408-050001 |
|
|
WEINSTEIN, HAREL |
HALLUCINOGENS & 5-HT2A
RECEPTORS: MECHANISMS AND EFFECTS |
|
5P01DA012923-04 |
|
|
WEINSTEIN, HAREL |
DISTINCTIVE
RECEPTOR ACTIONS IN HALLUCINOGEN MECHANISMS |
|
5P01DA012923-040001 |
|
|
WENSEL, THEODORE |
RGS
Domain Function in Mammalian Brain |
|
5R01DA015189-02 |
|
|
WHISTLER, JENNIFER |
G
Protein Coupled Receptor Trafficking and Opiate Drugs |
|
1R01DA015232-01A2 |
|
|
WHITE, FRANCIS |
Cocaine
and Mesolimbic Dopamine Electrophysiology |
|
5R37DA004093-19 |
|
|
WILSON, MARY |
Abused
NMDA Antagonists: Effects on Cortical Development |
|
5R21DA013992-02 |
|
|
WISE, ROY |
Intracranial
Drug Self-administration |
|
1Z01DA000439-03 |
|
|
WISE, ROY |
C-fos
Expression Induced By Tegmental Injections Of Chol |
|
1Z01DA000446-02 |
|
|
WOLF, MARINA |
Dopamine
and Glutamate Receptor Interactions |
|
1R01DA015835-01 |
|
|
WOLF, MARINA |
GLUTAMATE
AND PSYCHOSTIMULANT-INDUCED NEUROADAPTATIONS |
|
5K02DA000453-04 |
|
|
WOLF, MARINA |
GLUTAMATE
TRANSMISSION AND AMPHETAMINE SENSITIZATION |
|
5R01DA009621-08 |
|
|
|
|
No Names at this time.
|
|
|
|
|
|
|
|
|
|
Return to top |
|
|